Back to Journals » ClinicoEconomics and Outcomes Research » Volume 15

CELESTIA: Cost-Effectiveness Analysis of Empagliflozin Versus Sitagliptin in Patients with Type 2 Diabetes in Greece

Total article views   HTML views PDF downloads Totals
3,610 Dovepress* 3,421+ 164 3,585
PubMed Central* 189 82 271
Totals 3,610 246 3,856
*Since 17 February 2023

View citations on PubMed Central and Google Scholar